IP Library Granted Patent US 11,413,001
Granted Patent B2
US 11,413,001 · App. 16/295,149 · Granted Aug 16, 2022

System and methods for assessing presence of large vessel occlusion to aid in transfer decision-making for endovascular treatment in patients with acute ischemic stroke

Inventors: Mayank Goyal (Calgary, CA); Bijoy K. Menon (Calgary, CA)
Assignee: MG Stroke Analytics Inc.
A61B6/5217A61B6/032A61B6/501A61B6/504A61B6/507A61B6/5241G06T7/0016G06T7/62G16H30/40G06T2207/10072G06T2207/30016G06T2207/30104
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,413,001
App. No.
16/295,149
Granted
Aug 16, 2022
Kind
B2
Abstract

The invention relates to systems and methods to assist physicians in decision making for stroke patients. In particular the systems and methods can be used to assist physicians to decide on whether a patient with an acute ischemic stroke has a large vessel occlusion (LVO) and should be transferred from a community hospital to a larger hospital to undergo an endovascular thrombectomy procedure.

Claims (7)

1. A method of diagnosing vessel occlusion affecting tissue in a brain comprising the steps of:

performing a multi-phase computer tomography angiogram (mCTA) on a patient to obtain at least 3 phases of mCTA images across multiple levels of the brain, with the brain comprising an affected side and an unaffected side, wherein the affected side comprises an affected tissue and an unaffected tissue, where the mCTA includes injecting a single bolus of contrast and where a first phase of the at least 3 phases of mCTA images is timed to correspond with a peak contrast flow through the unaffected side and a final phase of the at least 3 phases of mCTA images is timed to correspond with a tail-end of contrast clearance through the unaffected side;

creating a voxel-by-voxel density map over the at least 3 phases of mCTA images;

creating a color-coded density map to identify the location of the affected tissue and the unaffected tissue based on the voxel-by-voxel density map;

calculating a total volume of affected tissue based on the color-coded density map;

comparing the color-coded density map to a standardized map of known vascular territories to determine a total volume of affected tissue in a known vascular territory and,

if the total volume of affected tissue in a known vascular territory is greater than a threshold volume, diagnose vessel occlusion and name location.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2019
From: GOYAL, MAYANK; MENON, BIJOY
To: MG STROKE ANALYTICS INC.
Reel/Frame 049488/0267 →
Continuity (2)
Provisional Application 62639914 · Mar 7, 2018
Related Publication 20190274652A1 · Sep 12, 2019